H2 Receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

H2 Receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program

Published:2018-06-15 Issue:12 Volume:197 Page:1638-1641
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Leary Peter J.¹^ORCID,Hess Edward²,Barón Anna E.²³,Branch Kelley R.¹,Choudhary Gaurav⁴⁵,Hough Catherine L.¹,Maron Bradley A.⁶⁷⁸,Ralph David D.¹,Ryan John J.⁹,Tedford Ryan J.¹⁰,Weiss Noel S.¹,Zamanian Roham T.¹¹,Lahm Tim¹²¹³

Affiliation:

1. University of WashingtonSeattle, Washington

2. Veterans Affairs Eastern Colorado Health Care SystemDenver, Colorado

3. Colorado School of Public HealthDenver, Colorado

4. Providence Veterans Affairs Medical CenterProvidence, Rhode Island

5. Alpert Medical School of Brown UniversityProvidence, Rhode Island

6. Veterans Affairs Boston Healthcare SystemBoston, Massachusetts

7. Brigham and Women’s HospitalBoston, Massachusetts

8. Harvard Medical SchoolBoston, Massachusetts

9. University of UtahSalt Lake City, Utah

10. Medical University of South CarolinaCharleston, South Carolina

11. Stanford UniversityStanford, California

12. Richard L. Roudebush Veterans Affairs Medical CenterIndianapolis, Indianaand

13. Indiana University School of MedicineIndianapolis, Indiana

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.201801-0048LE

Reference10 articles.

1. Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program

2. Updated Clinical Classification of Pulmonary Hypertension

3. Mediation of Subacute Anthracycline Cardiotoxicity in Rabbits by Cardiac Histamine Release

4. A histamine H2 receptor blocker ameliorates development of heart failure in dogs independently of β-adrenergic receptor blockade

5. Disruption of histamine H2 receptor slows heart failure progression through reducing myocardial apoptosis and fibrosis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mast Cells in Cardiac Remodeling: Focus on the Right Ventricle;Journal of Cardiovascular Development and Disease;2024-02-04

2. Associations of Histamine Metabolites with Disease Severity and Mortality in Pulmonary Arterial Hypertension;Annals of the American Thoracic Society;2023-11

3. Metabolomic Signatures Associated With Pulmonary Arterial Hypertension Outcomes;Circulation Research;2023-02-03

4. Histamine H ₂ Receptor Antagonists and Heart Failure Risk in Postmenopausal Women: The Women’s Health Initiative;Journal of the American Heart Association;2022-03

5. The Roles of Cardiovascular H2-Histamine Receptors Under Normal and Pathophysiological Conditions;Frontiers in Pharmacology;2021-12-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3